LikeFolio Weekly Roundup: SHOP, LEU & SOUN

We took a deep dive into Hims & Hers Health (HIMS) last week after legal threats from Novo Nordisk (NVO) sparked a sharp decline in the stock. On Saturday, the company buckled under the pressure and withdrew its low-cost semaglutide pill – sending the stock into a free fall this week.

It's clear that the powers that be don't want HIMS to succeed. That's the price of disruption. But this does not change our long-term outlook.

Hims & Hers is much more than a weight-loss company. It's a vertically integrated, direct-to-consumer (DTC) health platform spanning sexual health, dermatology, mental health, hormone therapy, peptides, metabolic panels, weight management, and now, cancer detection.

We told you last week that HIMS’ recent cancer screening launch was the more important story. That hasn’t changed. One in three Americans will develop cancer in their lifetime. HIMS is making early detection affordable to the masses. And demand remains elevated across categories.

Bottom line: We believe the company is well positioned with its growing consumer base to weather the storm and come out even more powerful on the other side.

The company is due to report earnings on Monday, February 23. Anything short of outstanding will be heavily scrutinized. But we’re holding onto this position because our conviction in the long-term thesis remains firmly intact.

For those who agree with our view, this pullback could be an extremely attractive accumulation opportunity.

Shopify (SHOP): Post-Earnings Deep Dive

LikeFolio member Frank M. wrote in this week to ask:

“Outstanding Gut Check Updates on HIMS and HOOD last week. Concise and to the point… Truly an educational masterclass! Would love to get similar analysis on both Shopify and SOFI when you have the time. Thanks, and appreciate the obvious hard work and excellent information you all consistently provide. Cheers! Double Martini”

This was an incredibly timely question after Shopify’s Q4 earnings release this week, which confirmed the strong holiday quarter our data predicted...

Let’s dig in.

Members Only Beyond This Point